MedPath

福州基石医药科技有限公司

Ownership
-
Established
2019-03-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

22

NMPA:22

Drug Approvals

Macrogol 4000 Powder

Product Name
聚乙二醇4000散
Approval Number
国药准字H20254313
Approval Date
May 27, 2025
NMPA

Potassium Chloride Granules

Product Name
氯化钾颗粒
Approval Number
国药准字H20254186
Approval Date
May 13, 2025
NMPA

Potassium Chloride Granules

Product Name
氯化钾颗粒
Approval Number
国药准字H20254185
Approval Date
May 13, 2025
NMPA

Macrogol 4000 Powder

Product Name
聚乙二醇4000散
Approval Number
国药准字H20253647
Approval Date
Mar 18, 2025
NMPA

Sodium Ibandronate Injection

Product Name
伊班膦酸钠注射液
Approval Number
国药准字H20237109
Approval Date
Sep 11, 2023
NMPA

Tobramycin Sulfate Injection

Product Name
硫酸妥布霉素注射液
Approval Number
国药准字H35020529
Approval Date
Jun 24, 2021
NMPA

Lidocaine Hydrochloride Injection

Product Name
盐酸利多卡因注射液(溶剂用)
Approval Number
国药准字H35020528
Approval Date
Jun 24, 2021
NMPA

Gentamycin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H35020524
Approval Date
Jun 23, 2021
NMPA

Vitamin C Injection

Product Name
维生素C注射液
Approval Number
国药准字H35020526
Approval Date
Jun 4, 2021
NMPA

Puerarin Injection

Product Name
葛根素注射液
Approval Number
国药准字H20044004
Approval Date
Jun 4, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.